Trial · NCT02010242
Results by group38
Each measurement the trial posted, group by group, in the words and numbers it posted.
21 to 38 of 38
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| eGFR Change by Study Visit | GKT137831 | Change in week 2 (Visit 6) eGFR from baseline | -0.5 | Standard Deviation 6.07 | mL/min/1.73m^2 |
| eGFR Change by Study Visit | Placebo | Change in week 2 (Visit 6) eGFR from baseline | -0.4 | Standard Deviation 7.27 | mL/min/1.73m^2 |
| eGFR Change by Study Visit | GKT137831 | Change in week 4 (Visit 7) eGFR from baseline | -0.6 | Standard Deviation 8.25 | mL/min/1.73m^2 |
| eGFR Change by Study Visit | Placebo | Change in week 4 (Visit 7) eGFR from baseline | -1.5 | Standard Deviation 6.55 | mL/min/1.73m^2 |
| eGFR Change by Study Visit | GKT137831 | Change in week 6 (Visit 8) eGFR from baseline | -0.1 | Standard Deviation 8.13 | mL/min/1.73m^2 |
| eGFR Change by Study Visit | Placebo | Change in week 6 (Visit 8) eGFR from baseline | -0.3 | Standard Deviation 6.80 | mL/min/1.73m^2 |
| eGFR Change by Study Visit | GKT137831 | Change in week 8 (Visit 9) eGFR from baseline | -1.1 | Standard Deviation 8.7 | mL/min/1.73m^2 |
| eGFR Change by Study Visit | Placebo | Change in week 8 (Visit 9) eGFR from baseline | -1.7 | Standard Deviation 7.31 | mL/min/1.73m^2 |
| eGFR Change by Study Visit | GKT137831 | Change in week 10 (Visit 10) eGFR from baseline | -0.7 | Standard Deviation 8.21 | mL/min/1.73m^2 |
| eGFR Change by Study Visit | Placebo | Change in week 10 (Visit 10) eGFR from baseline | -1.9 | Standard Deviation 7.89 | mL/min/1.73m^2 |
| eGFR Change by Study Visit | GKT137831 | Change in week 12 (Visit 11) eGFR from baseline | -1.5 | Standard Deviation 8.28 | mL/min/1.73m^2 |
| eGFR Change by Study Visit | Placebo | Change in week 12 (Visit 11) eGFR from baseline | -1.2 | Standard Deviation 8.08 | mL/min/1.73m^2 |
| eGFR Change by Study Visit | GKT137831 | Change in week 16 (Follow up) eGFR from baseline | -1.3 | Standard Deviation 8.21 | mL/min/1.73m^2 |
| eGFR Change by Study Visit | Placebo | Change in week 16 (Follow up) eGFR from baseline | -1.9 | Standard Deviation 10.45 | mL/min/1.73m^2 |
| Erectile Dysfunction | GKT137831 | 0.8 | Standard Deviation 5.86 | score on a scale | |
| Erectile Dysfunction | Placebo | -0.5 | Standard Deviation 5.06 | score on a scale | |
| Neuropathic Pain | GKT137831 | -15.3 | Standard Deviation 21.79 | score on a scale | |
| Neuropathic Pain | Placebo | -10.5 | Standard Deviation 22.18 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02010242/results?page=2